ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Pre-clinical Testing of Novel Glutamine Metabolic Inhibitors in MYC-driven Medulloblastoma||The Johns Hopkins University School of Medicine / Eric Raabe, MD/PhD & Dr. Barbara Slusher, PhD||Innovation Grants||2016||Maryland|
|Modeling Pediatric Spinal Gliomas Using Murine Spinal Neural Stem Cells||The Johns Hopkins University School of Medicine / Charles Eberhart, MD/PhD & Eric Raabe MD/PhD||Innovation Grants||2016||Maryland|
|The Role of ARID1A in Neuroblastoma Pathogenesis||Dana-Farber Cancer Institute / Hui Shi, PhD||Young Investigator Grants||2016||Massachusetts|
|Resistance and Develop Improved Treatments for Relapsed/refractory Pediatric ALL||Dana-Farber Cancer Institute / Elizabeth Townsend, PhD||Young Investigator Grants||2016||Massachusetts|
|Web-Based Cognitive-Behavioral Treatment for Insomnia in Adolescent Cancer Survivors||Dana-Farber Cancer Institute / Eric Zhou, PhD||Psychosocial Grants||2016||Massachusetts|
|Modeling RUNX1-Associated Clonal Hematopoietic Disorders in Zebrafish||Boston Children's Hospital / Leonard Zon, MD||Familial RUNX1 Research Grants||2016||Massachusetts|
|Pharmacologic Enhancement of Residual Wild Type RUNX1 Protein Activity in FPD/AML||Boston Children's Hospital / Alan Cantor, MD, PhD||Familial RUNX1 Research Grants||2016||Massachusetts|
|GeneEditing in T cell Leukemia to Promote Immunomodulatory Forms of Cell Death||Boston Children's Hospital / Dr. Ben Croker, PhD||Innovation Grants||2016||Massachusetts|
|Targeted Inhibition of Lin28/let-7 Binding to Treat Pediatric Malignancy||Boston Children's Hospital / George Q. Daley, MD/PhD||Innovation Grants||2016||Massachusetts|
|Molecular Basis of ALK Inhibition Resistance in High-risk Neuroblastoma||Dana-Farber Cancer Institute / David Debruyne, PhD||Young Investigator Grants||2016||Massachusetts|